Ardent Health files 8-K with Q3 2025 results press release

(Moderate)

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Ardent Health, Inc. (ARDT) furnished its third-quarter 2025 results press release. The company reported that, on November 12, 2025, it issued a press release covering financial results for the quarter ended September 30, 2025, and made it available as Exhibit 99.1 to a current report on Form 8-K under Item 2.02.

The information provided under Item 2.02, including Exhibit 99.1, is furnished rather than filed, meaning it is not subject to Section 18 of the Exchange Act and will only be incorporated by reference into other filings if expressly stated. The filing also lists Exhibit 104 for the cover page interactive data file. This is a routine disclosure that makes the company’s quarterly results press release part of the public record without triggering the liabilities associated with filed materials.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

What did Ardent Health (ARDT) announce in its 8-K?

It furnished a press release with financial results for the quarter ended September 30, 2025, as Exhibit 99.1.

Which 8-K item covers Ardent Health’s Q3 2025 results?

Item 2.02 (Results of Operations and Financial Condition).

When was the Ardent Health press release issued?

November 12, 2025.

Is the Q3 2025 press release considered filed or furnished?

It is furnished, not filed, and is not subject to Section 18 of the Exchange Act.

Which exhibits are included in the 8-K for ARDT?

Exhibit 99.1 (Press Release, dated November 12, 2025) and Exhibit 104 (Cover Page Interactive Data File).

Where is Ardent Health’s common stock listed and under what symbol?

On the New York Stock Exchange under the symbol ARDT.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

Accepted by SEC EDGAR 11/12/2025 - 04:32 PM



UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549


	FORM	8-K


CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 12, 2025




Ardent Health, Inc.
(Exact Name of Registrant as Specified in its Charter)


Delaware	001-42180	61-1764793
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)


340 Seven Springs Way, Suite 100, Brentwood, Tennessee		37027
(Address of Principal Executive Offices)		(Zip Code)

(615) 296-3000

(Registrant’s Telephone Number, including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

___________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under

any of the following provisions:


☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each Class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.01 par value per share	ARDT	New York Stock Exchange

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act

of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition

period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act. o

Item 2.02. Results of Operations and Financial Condition.

On November 12, 2025, Ardent Health, Inc. issued a press release announcing its financial results for the third quarter

ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and

is incorporated herein by reference.

The information in this Current Report on Form 8-K furnished pursuant to Item 2.02, including Exhibit 99.1, shall not be

deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),

or otherwise subject to the liabilities of that Section. This information shall not be incorporated by reference into any filing

under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically provided in any such

filing.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits:


Exhibit No.	Exhibit Description

Exhibit 99.1	Press Release, dated November 12, 2025

Exhibit 104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed

on its behalf by the undersigned hereunto duly authorized.


Dated: November 12, 2025	ARDENT HEALTH, INC.

	By:	/s/ Alfred Lumsdaine
	Name:	Alfred Lumsdaine
	Title:	Executive Vice President, Chief Financial Officer

Source: View Original Filing on SEC EDGAR